CNPFX
Price
$64.52
Change
+$0.06 (+0.09%)
Updated
May 22 closing price
Net Assets
147.5B
IYIGX
Price
$36.21
Change
-$0.04 (-0.11%)
Updated
May 22 closing price
Net Assets
896.63M
Interact to see
Advertisement

CNPFX vs IYIGX

Header iconCNPFX vs IYIGX Comparison
Open Charts CNPFX vs IYIGXBanner chart's image
American Funds New Perspective 529F
Price$64.52
Change+$0.06 (+0.09%)
VolumeN/A
Net Assets147.5B
Macquarie Global Growth Fund
Price$36.21
Change-$0.04 (-0.11%)
VolumeN/A
Net Assets896.63M
CNPFX vs IYIGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CNPFX vs. IYIGX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPFX is a Buy and IYIGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPFX has more cash in the bank: 148B vs. IYIGX (897M). CNPFX pays higher dividends than IYIGX: CNPFX (0.73) vs IYIGX (0.00). CNPFX was incepted earlier than IYIGX: CNPFX (23 years) vs IYIGX (12 years). IYIGX (1.45) is less costly to investors than CNPFX (0.84). IYIGX is a more actively managed with annual turnover of: 47.00 vs. CNPFX (24.00). IYIGX has a lower initial minimum investment than CNPFX: IYIGX (0) vs CNPFX (250). CNPFX annual gain was more profitable for investors over the last year : 7.60 vs. IYIGX (5.75). CNPFX return over 5 years is better than : 52.47 vs. IYIGX (-15.02).
CNPFXIYIGXCNPFX / IYIGX
Total Expense Ratio0.841.3562%
Annual Report Gross Expense Ratio0.841.4558%
Fund Existence23 years12 years-
Gain YTD6.2936.55596%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets148B897M16,499%
Annual Yield % from dividends0.730.00-
Returns for 1 year7.605.75132%
Returns for 3 years32.06-24.78-129%
Returns for 5 years52.47-15.02-349%
Returns for 10 years79.77-16.42-486%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL0.420.01
+3.02%
Lyell Immunopharma
MTNB0.77N/A
N/A
Matinas Biopharma Holdings Inc
BE18.21N/A
N/A
Bloom Energy Corp
TRVI6.18N/A
N/A
Trevi Therapeutics
EMN81.36-0.12
-0.15%
Eastman Chemical Company